We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Optimized Pooled Testing Approach Could Transform Public Health Screening for Infectious Diseases

By LabMedica International staff writers
Posted on 13 Dec 2024

Traditional individual testing methods can be resource-intensive, particularly when it comes to large-scale screenings. Pooled testing, on the other hand, enables the testing of multiple specimens together, which reduces both cost and time. This approach has been particularly useful in situations where disease prevalence is low, such as during early screenings or when monitoring for diseases like HIV and chlamydia. In an effort to accelerate and make large-scale disease testing more affordable, researchers have now created an optimized method for pooled testing, which has the potential to revolutionize public health screening for infectious diseases.

A study conducted by researchers at the University of Louisiana at Lafayette (Lafayette, LA, USA) examined the benefits of using pooled testing for detecting infectious diseases, particularly in cases of low prevalence. The team developed a framework to determine the most effective pool size for different infectious diseases, balancing both cost and testing efficiency. Their research utilized data on diseases like HIV, gonorrhea, chlamydia, and SARS-CoV-2.

The researchers found that by strategically pooling specimens, testing costs could be significantly reduced without sacrificing accuracy—an important discovery as health systems face increasing demand for screening across various diseases, including HIV, gonorrhea, and COVID-19. Their findings, published in the Journal of Agricultural, Biological, and Environmental Statistics, revealed that by adjusting pool sizes according to specific infection prevalence rates, public health agencies could realize considerable cost savings while still ensuring accurate prevalence estimates. The software tools developed in this study are now available for download, providing valuable resources for public health officials and researchers worldwide.

“Our findings suggest that careful design and optimization of pooled testing can yield substantial benefits for disease surveillance efforts, particularly in resource-limited settings,” said Dr. Md S. Warasi, Assistant Professor of Mathematics and Statistics at Radford University. “The study provides a new software package and a user-friendly software application to aid health departments and researchers in implementing these optimized testing protocols.”

“The ability to efficiently detect and monitor infectious diseases is crucial for timely interventions. By refining how pooled testing is conducted, we hope to empower health departments worldwide to improve their screening processes and respond faster to potential outbreaks,” added Dr. Kumer P. Das, Assistant Vice President for Research and Innovation at theUniversity of Louisiana at Lafayette.

 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.